(Q68707975)

English

In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO)

scientific article published on 01 February 1990

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

title

In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO) (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference

Johnson CS

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

Cook CA

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

Furmanski P

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

publication date

1 February 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

published in

Experimental Hematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

page(s)

109-113

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

retrieved

26 September 2019

Identifiers

PubMed publication ID

2303102

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2303102

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2303102%20AND%20SRC:MED&resulttype=core&format=json

(Q68707975)

In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)